We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.6B
AUM Growth
+$879M
(+4.7%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-6.05%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
589
New
74
Increased
137
Reduced
233
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$96.2M |
| 2 |
DraftKings
DKNG
|
+$81.7M |
| 3 |
GE HealthCare
GEHC
|
+$81.1M |
| 4 |
GFL Environmental
GFL
|
+$77M |
| 5 |
Vaxcyte
PCVX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$187M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$143M |
| 3 |
AbbVie
ABBV
|
+$112M |
| 4 |
Walt Disney
DIS
|
+$99.6M |
| 5 |
HSKA
Heska Corp
HSKA
|
+$80.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 10.17% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Automatic Data Processing
ADP
$106B
| $18.2K | ﹤0.01% |
83
-267
| -76% | -$57.6K |
|
502
RPM International
RPM
$14.3B
| $18.2K | ﹤0.01% |
203
| – | – |
|
503
Toro Company
TTC
$9.08B
| $17.8K | ﹤0.01% |
175
-257
| -59% | -$26.4K |
|
504
Valmont Industries
VMI
$9.33B
| $17.5K | ﹤0.01% |
60
-65
| -52% | -$18.8K |
|
505
United Rentals
URI
$67.9B
| $17.4K | ﹤0.01% |
39
-19,922
| -100% | -$7.38M |
|
506
Microchip Technology
MCHP
$41.1B
| $16.6K | ﹤0.01% |
185
-90,261
| -100% | -$7.12M |
|
507
Evolent Health
EVH
$421M
| $3.85K | ﹤0.01% |
127
-1,350,978
| -100% | -$43.7M |
|
|
NVO
508
Novo Nordisk
NVO
$225B
| $2.59K | ﹤0.01% |
32
+4
| +14% | +$327 |
|
509
Grupo Aeroportuario Centro Norte
OMAB
$5.23B
| $1.87K | ﹤0.01% |
22
| – | – |
|
510
DoubleVerify
DV
$1.73B
| $1.48K | ﹤0.01% |
+38
| New | +$1.23K |
|
511
Alcon
ALC
$33.7B
| $739 | ﹤0.01% |
9
-10
| -53% | -$764 |
|
512
Arch Capital
ACGL
$37.2B
| – | – |
-485
| Closed | -$32.9K |
|
|
ACLX
513
DELISTED
Arcellx
ACLX
| – | – |
-14,374
| Closed | -$443K |
|
514
ADC Therapeutics
ADCT
$141M
| – | – |
-125,985
| Closed | -$246K |
|
515
Ameresco
AMRC
$1.04B
| – | – |
-372,992
| Closed | -$18.4M |
|
516
Digital Turbine
APPS
$1.02B
| – | – |
-102,910
| Closed | -$1.27M |
|
517
Arhaus
ARHS
$1.12B
| – | – |
-8
| Closed | -$66 |
|
518
Brown-Forman Class B
BF.B
$13.3B
| – | – |
-332
| Closed | -$21.3K |
|
519
Baker Hughes
BKR
$58B
| – | – |
-130,910
| Closed | -$3.78M |
|
520
Biomea Fusion
BMEA
$90.4M
| – | – |
-16,689
| Closed | -$518K |
|
521
Burlington
BURL
$23.3B
| – | – |
-10,232
| Closed | -$2.07M |
|
522
CareDx
CDNA
$1.85B
| – | – |
-35
| Closed | -$320 |
|
523
C.H. Robinson
CHRW
$20B
| – | – |
-230
| Closed | -$22.9K |
|
524
Compass Therapeutics
CMPX
$367M
| – | – |
-403,062
| Closed | -$1.32M |
|
525
Cooper Companies
COO
$14.1B
| – | – |
-32,368
| Closed | -$3.02M |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2023 Portfolio in Review
As of Q2 2023, Fred Alger Management held 589 positions worth $19.6B, up 4.7% from $18.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fred Alger Management withdrew a net $1.18B in Q2 2023, closing 78 positions and reducing 233 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in DraftKings worth $94.2M.
- Fred Alger Management's largest Q2 2023 buy was DraftKings: 3,544,411 shares worth $94.2M.
- Fred Alger Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $96.2M increase.
- Fred Alger Management's biggest Q2 2023 reduction was Intuit, cutting an estimated $187M.
- Fred Alger Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $143M.
- Fred Alger Management's ten largest holdings make up 34% of its $19.6B portfolio in Q2 2023.
- Fred Alger Management opened 74 new positions and closed 78 in Q2 2023.
- Fred Alger Management's portfolio value rose 4.7% quarter-over-quarter to $19.6B.
Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.